Portugal
Competition Authority investigates purchase of BabyLife by Cryoestaminal and delays business in cryopreservation
Publication: ECO
Author: Mariana Bandeira
Source published: 29/09/2026, 10:37:23 UTC
Briefing created: 29/09/2026, 10:56:53 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 29/09/2026, 10:41:24 UTC.
Briefings
The Autoridade da Concorrência (AdC) initiated an investigation into the acquisition of Crioestaminal by Stamcriovitae, which aims to expand the country's cryopreservation sector. The transaction was notified in mid-May and is currently under review by the regulator led by Nuno da Cunha Rodrigues. The involved companies operate directly in the field, with Stamcriovitae holding the stake in Crioestaminal. The acquisition follows a history of consolidating the national market, with Crioestaminal previously acquiring Bébécord and Bébé4D in 2019 and 2023 respectively. The evidence covers the period from May 2023 to the present, with a snapshot limitation to the current investigation status.
Key points
- The Autoridade da Concorrência (AdC) initiated an investigation into the acquisition of Crioestaminal by Stamcriovitae, which aims to expand the country's cryopreservation sector.
- The transaction was notified in mid-May and is currently under review by the regulator led by Nuno da Cunha Rodrigues.
Context and limitations
The evidence covers the period from May 2023 to the present, with a snapshot limitation to the current investigation status.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 29/09/2026, 10:56:53 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeigsgujiwxnjtpnuy2vpqhpbwr56tsza7epvf3ck7hyejvsyakfw3m